trimetazidine dihydrochloride Tablets, sustained release (SR) 20 mg, 35 mg, 60 mg

The company is a pharmaceutical manufacturer focused on maintaining high-quality standards as a key competitive advantage, demonstrated by its ISO 9001:2015 accreditation and frequent quality audits. With a diverse product portfolio that spans therapeutic areas such as cardiology, diabetology, gynecology, neuro-psychiatry, orthopedics, and dermatology, the company is recognized for several top-performing brands in the Indian pharmaceutical market. Emphasizing practical application of research, the company actively participates in medical conferences, reflecting its commitment to ongoing professional development and engagement within the healthcare community.